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Activator of G Protein Signaling 3: A Gatekeeper
of Cocaine Sensitization and Drug Seeking
electrophysiology (Henry and White, 1995; Shoji et al.,
1997). While the accumulating evidence poses reduced
Gi-coupled cell signaling as important in cocaine ad-
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diction, specific cellular changes that might cause thisStephen M. Lanier,2 and Peter W. Kalivas1,*
deficit are not known and may involve accessory pro-1Department of Physiology and Neuroscience
teins that influence the transfer of signal from receptorMedical University of South Carolina
to G protein or directly regulate the activation state ofCharleston, South Carolina 29425
G proteins (Blumer and Lanier, 2003; Ribas et al., 2002).2 Department of Pharmacology
Two families of G protein regulators are important toand Experimental Therapeutics
the specificity and kinetics of the G protein signalingLouisiana State University Health Sciences Center
cascade. One family of G protein modulators, the regula-New Orleans, Louisiana 70112
tors of G protein signaling (RGS), regulates signaling
through G by stimulating GTPase activity or blocking
effector activation by G proteins (De Vries et al., 2000).Summary
Some members of the RGS family are regulated by co-
caine. The mRNAs encoding RGS2, 3, 4, and 5 are upreg-Chronic cocaine administration reduces G protein sig-
ulated in the striatum by acute psychostimulant adminis-naling efficacy. Here, we report that the expression
tration (Bishop et al., 2002; Burchett et al., 1999), andof AGS3, which binds to GiGDP and inhibits GDP
the protein content of RGS9 is increased by chronicdissociation, was upregulated in the prefrontal cortex
cocaine (Rahman et al., 2003). In this report, we investi-(PFC) during late withdrawal from repeated cocaine
gate a potential role in the cellular and behavioral conse-administration. Increased AGS3 was mimicked in the
quences of chronic cocaine administration for a memberPFC of drug-naive rats by microinjecting a peptide
of the other family of G protein regulators, the activatorcontaining the Gi binding domain (GPR) of AGS3
of G protein signaling (AGS) family.fused to the cell permeability domain of HIV-Tat. Infu-
The AGS family consists of three structurally and func-sion of Tat-GPR mimicked the phenotype of chronic
tionally distinct members that were identified in a yeast-cocaine-treated rats by manifesting sensitized loco-
based functional screen for mammalian cDNAs that acti-motor behavior and drug seeking and by increasing
vated G protein signaling in the absence of a receptorglutamate transmission in nucleus accumbens. By
(Takesono et al., 1999). AGS1, a ras-related protein alsopreventing cocaine withdrawal-induced AGS3 expres-
known as RASD1, promotes nucleotide exchange by Gi/sion with antisense oligonucleotides, signaling through
Go and thereby stimulates G protein activation. AGS2Gi was normalized, and both cocaine-induced relapse
interacts with G and is absent in brain (Blumer andto drug seeking and locomotor sensitization were pre-
Lanier, 2003). AGS3 is enriched in neurons (Blumer etvented. When antisense oligonucleotide infusion was
al., 2002), contains no structural homology with AGS1discontinued, drug seeking and sensitization were re-
or AGS2 (Blumer and Lanier, 2003), and is the first knownstored. It is proposed that AGS3 gates the expression
G protein dissociation inhibitor for heterotrimeric G pro-of cocaine-induced plasticity by regulating G protein
teins (Takesono et al., 1999).signaling in the PFC.
AGS3 consists of seven tetratricopeptide repeats in
the amino terminus, which is followed by an100 aminoIntroduction
acid linker region connecting four 25 amino acid G
protein regulator (GPR) motifs in the carboxyl domain.
Enduring molecular changes associated with chronic
The GPR repeats selectively stabilize up to four Gi1-3
cocaine administration and withdrawal are believed to subunits in the inactive GDP conformation, thereby in-
mediate addiction and relapse to drug taking (Berke and hibiting Gi binding to G (Bernard et al., 2001; Pe-
Hyman, 2000; Nestler, 2001). Neuroimaging experiments terson et al., 2002; Takesono et al., 1999). In heterolo-
with nonhuman primates (Morgan et al., 2002) and hu- gous systems, Gi complexed with a GPR motif is not
man addicts (Goldstein and Volkow, 2002) suggest that recognized by either receptor or effector (Peterson et
reduced signaling through Gi-coupled receptors may al., 2000). Thus, overexpression of AGS3 may selectively
be an important neuroadaptation in cocaine addiction. regulate receptor signaling through Gi without affect-
Also, in vivo studies in rodents demonstrate that reduc- ing signaling through receptors that couple to other G
ing Gi with pertussis toxin alters the expression of proteins (Bernard et al., 2001; Peterson et al., 2002;
cocaine-induced sensitization and self administration Takesono et al., 1999).
(Self et al., 1994; Steketee and Kalivas, 1991). More To begin investigating if the regulation of Gi by AGS3
direct evidence of reduced Gi function has been ob- is relevant to cocaine addiction, immunoblots were ob-
served following repeated cocaine administration at the tained following withdrawal from repeated administra-
level of protein expression (Nestler et al., 1990; Striplin tion of cocaine, and AGS3 expression was upregulated
and Kalivas, 1993), Gi-mediated signaling events (Xi in the prefrontal cortex (PFC) and core compartment of
et al., 2003, 2002; Zhang et al., 2000), and membrane the nucleus accumbens. Given the inhibitory role of
AGS3 upon Gi activation and reduced signaling
through Gi during cocaine withdrawal, alterations in*Correpondence: kalivasp@musc.edu
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Figure 1. AGS3 Was Upregulated during Withdrawal from Repeated Cocaine Administration
(A and B) After 3 and 8 weeks of withdrawal, AGS3 was upregulated in the prefrontal cortex (PFC) and nucleus accumbens core (NAcore) but
not in the shell of the nucleus accumbens (NAshell), the dorsal striatum (STR), or the ventral tegmental area (VTA). (C) AGS3 was elevated in
the PFC at 3 weeks after discontinuing cocaine self administration compared with yoked saline control subjects. Representative blots of
AGS3 (A and C) are shown as well as blots probed for calnexin, an integral membrane protein of the endoplasmic reticulum, to demonstrate
even loading across the gel. Odd numbers, repeated saline group; even numbers, repeated cocaine group. Data were normalized to percent
change from saline control values within each blot. *p  0.05, comparing withdrawal from repeated saline to withdrawal from repeated cocaine
using a two-tailed unpaired Student’s t test.
AGS3 levels in the PFC and accumbens core are consis- striatum (Figure 1A). By 8 weeks of withdrawal, the levels
of AGS3 remained elevated in the accumbens core, andtent with the fact that the glutamatergic projection from
the PFC to the accumbens core is necessary for the while significantly elevated above control in the PFC, the
levels were reduced compared to 3 weeks of withdrawalexpression of addiction-related behaviors (Li et al.,
1999a; McFarland and Kalivas, 2001; Pierce et al., 1998). (Figure 1B). AGS3 expression was not different between
repeated cocaine and saline treatment groups at earlierAlso, cocaine addiction is associated with reduced PFC
function, including deficits in adaptive decision making withdrawal time points (1 and 7 days) or after acute
cocaine treatment in any brain region examined (Tablesand impulse control (Bonson et al., 2002; Goldstein and
Volkow, 2002). Accordingly, experiments were conducted 1 and 2). Finally, animals were trained to self administer
cocaine for 2 weeks, and after 3 weeks of withdrawal,to determine if the upregulation of AGS3 in the PFC may
mediate the behavioral and neurochemical phenotype the level of AGS3 in the PFC was elevated compared
with yoked saline control subjects (Figure 1C).observed during withdrawal from repeated cocaine ad-
ministration. AGS3 levels in the PFC were pharmacologi-
cally regulated using antisense oligonucleotides and a Elevating AGS3 Caused a Cocaine
Sensitization-like PhenotypeTat-GPR fusion peptide, and effects were measured on
receptor coupling to Gi, glutamate release, locomotor Gi inhibition by AGS3 can be mimicked by a consensus
peptide derived from the four GPR domains containedactivity, and the reinstatement of cocaine seeking.
within AGS3, and a single point mutation in the GPR
domain (mGPR) abolishes Gi binding (Bernard et al.,Results
2001; Peterson et al., 2002). The GPR peptides were
rendered cell permeable by fusing the protein transduc-Increased AGS3 Expression during Withdrawal
Immunoblots were obtained in tissue collected from the tion domain from HIV-Tat to the amino terminus of the
GPR consensus peptide (Schwarze et al., 1999). Likebrain regions that are commonly associated with the
effects of abused drugs (Everitt and Wolf, 2002). In- the GPR domain of AGS3, Tat-GPR peptides inhibited
[35S]GTPS binding to purified Gi, while Tat-mGPR wascreased content of AGS3 was observed in the PFC and
the core region of the nucleus accumbens following 3 without effect (Figure 2A). Also, high-affinity agonist
binding to 2A/D adrenergic receptors in DDT-MF2 cellweeks of withdrawal from repeated cocaine but not in
the shell of the accumbens, ventral tegmental area, or membrane extracts was inhibited by Tat-GPR but not
Table 1. Mesocorticolimbic AGS3 Expression following Withdrawal from Repeated Cocaine
24 Hrs Withdrawal 1 Week Withdrawal
Sal (O.D.) Coc (O.D.) Sal (O.D.) Coc (O.D.)
PFC 100  5.5 (5) 104.7  8.7 (5) 100  7.3 (5) 101.9  7.4 (6)
NAc 100  9.2 (6) 116.2  10.6 (6) 100  8.6 (6) 130.9  17.8 (5)
NAs 100  5 (6) 93.5  5 (6) 100  17.4 (6) 121.2  18.4 (5)
STR 100  9.5 (4) 113.7  14.1 (5) 100  4.3 (6) 99.6  9 (6)
VTA 100  9.2 (6) 108.3  9.2 (6) 100  8.3 (6) 80.9  12.3 (6)
Data are expressed as percent expression in optical density values from animals treated with acute saline at equivalent withdrawal periods 
SEM (n). NAc, nucleus accumbens core; NAs, nucleus accumbens shell; PFC, prefrontal cortex; STR, striatum; VTA, ventral tegmental area;
Sal, saline; Coc, cocaine; ND, not determined.
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Table 2. Mesocorticolimbic AGS3 Expression following Withdrawal from Acute Cocaine
1 Week Withdrawal 3 Weeks Withdrawal
Sal (O.D.) Coc (O.D.) Sal (O.D.) Coc (O.D.)
PFC 100  5.5 (4) 108.5  4.2 (4) 100  19.3 (6) 90.9  15.9 (6)
NAc 100  19.2 (4) 116.3  12.5 (4) 100  12.4 (6) 94.0  7.5 (6)
NAs 100  4.2 (4) 109.9  2.6 (4) 100  1.6 (6) 97.6  4.9 (6)
STR 100  16.5 (4) 100.7  1.7 (4) 100  20.8 (6) 103.2  16.7 (6)
VTA 100  16.1 (4) 107.2  37.7 (3) ND ND
Data are expressed as percent expression in optical density values from animals treated with acute saline at equivalent withdrawal periods 
SEM (n). NAc, nucleus accumbens core; NAs, nucleus accumbens shell; PFC, prefrontal cortex; STR, striatum; VTA, ventral tegmental area;
Sal, saline; Coc, cocaine; ND, not determined.
by Tat-mGPR (Figure 2B). Thus, Tat-GPR effectively response was markedly enhanced between 10 and 60
min after cocaine injection in Tat-GPR-pretreated ani-mimicked the ability of the AGS3 GPR domain to inhibit
Gi. It should be noted that in the brain LGN, Rap1Gap, mals, compared to subjects microinjected with Tat-
mGPR (Figures 4A and 4B). In contrast, there was noRGS12, and RGS14 contain at least one GPR domain
each (Blumer and Lanier, 2003), and increasing intracel- difference in behavioral activation produced by injecting
lular content of the four GPR domains contained in AGS3
by Tat-GPR could also be mimicking the action of
these proteins.
A Tat-fluorescein conjugate was microinjected into
the PFC, and in vivo transduction of cells was examined
30 min following microinjection. Transduction of both
neurons and glia was found at the site of microinjection
(Figures 3A and 3B). Nissl staining of adjacent sections
revealed an abundance of healthy-appearing neurons
and no apparent neurotoxicity outside the mechanical
damage resulting from cannula implantation (Figure 3C).
Immunoblotting for Tat-GPR at different times after mi-
croinjection into the PFC revealed maximum Tat-GPR
content at 30 min that gradually diminished to undetect-
able levels by 120 min (Figure 3D).
The behavioral effect of transducing PFC cells with
Tat-GPR was examined in drug-naive animals using
photobeam breaks to estimate locomotor activity. Thirty
minutes after microinjecting Tat-peptide, cocaine (15
mg/kg, i.p.) was administered, and the motor stimulant
Figure 3. Tat-Peptides Were Efficiently Transduced and Exhibited
No Apparent Toxicity
(A) Epifluorescent micrograph illustrates Tat-fluorescein-containing
cells at the tip of the microinjection cannulae 30 min after microinjec-
Figure 2. Tat-GPR Prevents Gi Signaling tion. Cannulae placements are within area Cg3 (Paxinos and Watson,
1998) near the prelimbic/infralimbic border of the PFC. Scale bar,(A) [35S]GTPS binding to 100 nM purified Gi was blocked by in-
creasing concentrations of Tat-GPR (100 M), while Tat-mGPR (100 1 mm; cc, corpus callosum. (B) Tat-fluorescein fills the cell bodies
of pyramidal neurons and extends into the dendrites (white triangle).M) was ineffective. (B) High-affinity (4 nM [3H]-UK14304) binding
in DDT1-MF2 membranes stably expressing the 2A/D adrenergic Astroglia were also transduced (black triangle). Scale bar, 100 m;
cc, corpus callosum. (C) Nissl staining revealed an abundance ofreceptor was inhibited by Tat-GPR but not by Tat-mGPR. N.S.,
nonspecific binding; GppNHp, guanyly imidodiphosphate is a non- healthy-appearing neurons at the infusion site. (D) A pan GPR anti-
body illustrates that after microinjection into the PFC, Tat-GPR (4hydrolyzable form of GTP that produced maximal reduction in [3H]-
UK14304 binding. Data depict mean  SEM, n  2–5, run in dupli- kDa) is cleared within 120 min. Crossreactivity of the GPR antibody
to AGS3 (74 kDa) demonstrated even gel loading. Veh, vehicle ad-cate. *p 0.01, using two-tailed unpaired Student’s t test comparing
Tat-GPR with Tat-mGPR ministration.
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Figure 4. Tat-GPR in the PFC Produces a Sensitization-like Behavioral and Neurochemical Phenotype
(A and B) Microinjection of Tat-GPR into the PFC produced a sensitized motor response to cocaine (15 mg/kg, i.p.) in drug-naive subjects.
Animals were habituated to the test chamber (time, 60–0), microinjected with either Tat-GPR or Tat-mGPR (time, 0) and injected with cocaine
or saline (time, 30). Data points depict mean distance traveled or number of stereotypies  SEM, n  8. (C) Microinjection of Tat-GPR into
the PFC augmented the reinstatement of drug seeking (active lever pressing) by a cocaine priming injection (5 mg/kg, i.p.). Two reinstatement
trials were conducted in animals extinguished to criterion (Ext I and Ext II), and Tat-GPR or Tat-mGPR were administered 30 min prior to the
cocaine priming injection in random order. Data are shown as mean  SEM; active lever presses, n  9. Ext, number of active lever presses
on the day of extinction training prior to the reinstatement trial. (D) Cocaine-induced (15 mg/ kg, i.p.) increase in extracellular glutamate in
the accumbens core was augmented by pretreatment of the PFC with Tat-GPR. Data points depict mean  SEM pmol/dialysis sample, n 
8. Tat-peptide, either Tat-GPR or Tat-mGPR. Challenge, either cocaine (15 mg/kg, i.p.) or saline (1 ml/kg, i.p.). *p  0.05, using a two-way
ANOVA with repeated measures over time using a least significant difference test for posthoc comparisons of Tat-GPR to TAT-mGPR (A, B,
and D) or a two-tailed paired Student’s t test (C).
saline between the Tat-GPR and Tat-mGPR-pretreated lowing extinction training were administered an injection
of cocaine at a dose (5 mg/kg, i.p.) that produces sub-groups (Figures 4A and 4B). Both distance traveled (esti-
mate of locomotion, Figure 4A) and number of stereo- maximal reinstatement of drug seeking (Baker et al.,
2003). Two separate reinstatement trials were con-typies (repeated breaking of the same photocell beam
to estimate stereotyped behavior, Figure 4B) were aug- ducted, and animals were microinjected with either Tat-
GPR or Tat-mGPR in counterbalanced order 30 min priormented by Tat-GPR, indicating that the increase in mo-
tor activity probably did not involve switching between to injecting cocaine (Figure 4C shows protocol). The
number of active lever presses elicited by cocaine wascompeting behaviors but rather that inhibition of Gi
by Tat-GPR imparts increased sensitivity to the motor- significantly augmented in the group pretreated with
Tat-GPR (Figure 4C).stimulant properties of cocaine. In the experiment
shown in Figures 4A and 4B, subjects were microin- Animals that develop behavioral sensitization or have
been trained to self administer cocaine demonstrate anjected with Tat-GPR or Tat-mGPR at 1 week intervals
in a random design such that each animal received all elevation in extracellular glutamate in the core compart-
ment of the nucleus accumbens following a subsequentfour treatments. Thus, in accord with the apparent short
half-life of the Tat-GPR fusion peptide (Figure 3D), the injection of cocaine and/or exposure to an environment
that was paired with cocaine administration, and thecapacity of Tat-GPR pretreatment to produce a sensiti-
zation-like augmentation in the behavioral stimulant ef- enhanced glutamate release arises primarily from pre-
frontal cortical glutamatergic afferents (Hotsenpiller etfect of cocaine was reversible.
In addition to motor stimulation, the capacity of Tat- al., 2001; Li et al., 1999a; McFarland et al., 2003; Pierce et
al., 1996, 1998). Corresponding with Tat-GPR inducing aGPR to potentiate cocaine-primed reinstatement of drug
seeking was examined (Figure 4C). The reinstatement behavioral sensitization-like phenotype, cocaine pro-
duced an increase in extracellular glutamate in the ac-of drug-seeking behavior is a widely employed animal
model of relapse (Shalev et al., 2002). Animals were cumbens core of drug-naive animals following Tat-GPR
pretreatment of the PFC (Figure 4D). Similar to previoustrained to self administer intravenous cocaine and fol-
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Figure 5. Regulating AGS3 Expression with
Antisense Oligonucleotides
(A) AGS3 was downregulated following either
1 or 2 weeks of continuous infusion of anti-
sense into the PFC and returned 2 weeks after
antisense infusion was terminated. (B) Animals
were injected with daily saline or cocaine for 1
week, oligonucleotide was bilaterally infused
for 2 weeks, pumps were removed, and 2
weeks later, levels of AGS3 in PFC were mea-
sured. AS-1, antisense flanking the AGS3 ini-
tiation codon; Sc, a scrambled form of AS-1
that does not bind any known gene; AS-2,
antisense directed entirely within the AGS3
open reading frame. Data points are depicted
as mean  SEM percent change in optical
density from scrambled (A) or chronic saline 	 scrambled (B). n is indicated in each bar. *p  0.05, comparing AS-1 or AS-2 with SC using
a two-tailed paired Student’s t test. #p  0.05, comparing chronic saline with chronic cocaine; a two-way ANOVA revealed a significant effect
of chronic treatment but no effect of oligonucleotide or interaction between chronic drug and oligonucleotide.
reports in drug-naive animals (McFarland et al., 2003; tides (Braasch and Corey, 2002). Due to using low con-
centrations and having only the five terminal basesSmith et al., 1995), extracellular glutamate in the accum-
bens core was not altered by an acute injection of co- phosphorotioate substituted, after 2 weeks of infusion,
no evidence of neurotoxicity was found outside of thecaine (15 mg/kg, i.p.) in animals pretreated with Tat-
mGPR (Figure 4D). mechanical disruption produced by implantation of the
infusion cannula (Figure 6). Nissl staining revealed an
abundance of healthy-appearing cells (Figures 6B, 6E,Antisense Oligonucleotides Reversibly
Lower Levels of AGS3 and 6H), and staining for glial proliferation with glial
fibrillary acidic protein (GFAP) showed equivalent stain-An antisense oligonucleotide strategy was used during
withdrawal to reversibly inhibit the increase in AGS3 in ing between the three oligonucleotide infusion groups
(Figures 6C, 6F, and 6I).the PFC. Two antisense constructs, one that flanked the
AGS3 initiation codon (AS-1) or one directed within the
AGS3 open reading frame (AS-2), were continuously in- Elevated AGS3 Contributes to Reduced Gi
Signaling Produced by Repeated Cocainefused bilaterally into the PFC using subcutaneously
implanted osmotic minipumps. To determine a concen- The effect of increased AGS3 expression on G protein
signaling after 3 weeks of withdrawal from repeatedtration of AS that would restore the cocaine withdrawal-
elevated AGS3 content to approximate control levels exposure to cocaine was assayed via agonist-induced
guanosine 5
-[-35S]thiotriphosphate ([35S]GTPS) bind-(e.g.,40% reduction, see Figure 1A), AS-1 or AS-2 was
continuously infused into one side of the PFC for 1–2 ing in ex vivo PFC membranes with ligands selective
for Gi-coupled group II metabotropic glutamate recep-weeks. A scrambled oligonucleotide sequence was in-
fused into the opposite hemisphere as a control. An tors (mGluR2/3) and D2/3 dopamine receptors, or
Gs-coupled D1 dopamine receptors. At 1 week afterantisense infusion rate of 504 pmol/24 hr was found to
reduce AGS3 expression by 35%–60% (Figure 5A). the last daily cocaine or saline injection, either scram-
bled oligonucleotide or AS-1 was infused into the PFCAdditional immunoblotting revealed that 2 weeks of AS-1
infusion did not affect expression of proteins in the PFC for 2 weeks. Following infusion of scrambled oligonu-
cleotide, [35S]GTPS binding induced by stimulatingthat are functionally related to signaling though Gi in-
cluding Gi1,3 (111%  9.5%; n  8; mean optical mGluR2/3 or dopamine D2/3 receptors with 2R,4R-4-
aminopyrrolidine-2,4-dicaroxylate (APDC) or quinpirole,density SEM change from scrambled oligonucleotide)
or G (110%11%; n8). In some animals, the osmotic respectively, was significantly decreased after with-
drawal from cocaine, compared with control subjectsminipumps were removed after 2 weeks to determine if
the reduction in AGS3 by AS-1 was reversible. Two (e.g., compare Sc 	 Coc with Sc 	 Sal in Figures 7A
and 7B). Agonist-induced [35S]GTPS binding was re-weeks after discontinuing oligonucleotide infusion,
AGS3 content was equivalent between the AS-1 and stored in rats withdrawn from repeated cocaine to levels
equivalent to control by infusing AS-1 (e.g., no signifi-scrambled control group (Figure 5A). Moreover, animals
were administered daily saline or cocaine for 7 days cant difference existed between AS 	 Coc, Sc 	 Sal,
and AS 	 Sal groups). In contrast, AS-1 in repeatedand 1 week later implanted with bilateral minipumps to
deliver AS-1 or scrambled oligonucleotide into the PFC saline animals did not significantly alter the level of quin-
pirole-stimulated [35S]GTPS binding (this treatmentfor 2 weeks. Two weeks following pump removal, the
level of AGS3 in the PFC of both oligonucleotide groups group was not examined with APDC treatment, Figure
7B). Consistent with the selective binding of AGS3 towas elevated in the animals treated with chronic cocaine
compared with chronic saline (Figure 5B), indicating that Gi (Bernard et al., 2001), [35S]GTPS binding induced
by stimulating the Gs-coupled dopamine D1 receptorscocaine-induced elevations in AGS3 were restored after
discontinuing AS-1 infusion. was equivalent in all groups (Figure 7C). The restoration
of quinpirole and APDC-induced [35S]GTPS binding byNeurotoxicity is produced by relatively high concen-
trations of phosphorothioate-substituted oligonucleo- AS-1 was not associated with alterations in PFC content
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Decreasing AGS3 Reversibly Inhibits
Behavioral Sensitization
Repeated exposure to cocaine produces an enduring
augmentation (sensitization) in the motor stimulant ef-
fects of a subsequent cocaine injection (Everitt and Wolf,
2002). Some lesion studies (Pierce et al., 1998; Tzschen-
tke and Schmidt, 1999), but not all (Li et al., 1999b),
demonstrate that the glutamatergic PFC projection to
the core of the nucleus accumbens is necessary for the
expression of behavioral sensitization following re-
peated cocaine administration. Experiments were con-
ducted to determine if the upregulation of AGS3 in the
PFC during withdrawal from repeated treatment with
cocaine contributes to the expression of cocaine-sensi-
tized motor behavior.
Rats were repeatedly administered intraperitoneal co-
caine for 1 week, and following 1 week of withdrawal,
osmotic minipumps were implanted to deliver AS-1 or
scrambled oligonucleotide into the PFC (Figure 8A).
After 2 weeks of oligonucleotide infusion, all animals
were administered cocaine (15 mg/kg, i.p.) to test for
the presence of a sensitized motor response. The pumps
were removed, and 2 weeks later, all animals were again
tested for the presence of behavioral sensitization to
cocaine. The first injection of cocaine (i.e., on day 1
before oligonucleotide infusion) elicited an equivalent
motor response in both groups (Figure 8B). Following 3
weeks of withdrawal from daily cocaine and 2 weeks of
oligonucleotide infusion, the motor response to cocaine
in the scrambled group was significantly augmented
compared to day 1 (Figures 8B and 8C). In contrast,
infusion of AS-1 inhibited the expression of a sensitized
motor response (day 28; Figures 8B and 8C). Two weeks
following pump removal, both oligonucleotide groups
showed significant and equivalent behavioral sensitiza-
tion in response to an injection of cocaine (Figure 8D).
The sensitized response in the scrambled group was
equivalent between days 28 and 42, while the response
on day 42 was significantly increased over day 28 in the
AS-1 group. Thus, in accord with the protein expression
studies (Figure 5), the inhibition of sensitized motor ac-
tivity by AS-1 was reversible.
In contrast to the marked effect of AS-1 on the expres-
sion of the sensitized motor response to cocaine, 2
weeks of AS-1 infusion did not affect the motor stimulant
response to an acute injection of cocaine (15 mg/kg, i.p.)Figure 6. Lack of Neurotoxicity after 2 Weeks of Oligonucleotide
Infusion into the PFC in drug-naive rats (Figure 8E). Similarly, the exploratory
response to novelty (habituation to the photocell cham-(A, D, and G) Cannulae placements were near the prelimbic/infralim-
bic border of the PFC (Paxinos and Watson, 1998). Scale bar, 1 mm; ber) or the locomotor response to an acute injection of
cc, corpus callosum. (B, E, and H) Visual inspection of Nissl staining saline was not affected by AS-1 infusion (Figure 8E).
for chromatolysis and microglial reactivity directly below the infusion
site revealed an abundance of healthy-appearing neurons. (C, F,
Decreasing AGS3 Reversibly Inhibits Cocaineand I) No difference was detected between treatments when glial
Reinstatement of Drug Seekingfibrillary acidic protein (GFAP) immunoreactivity was utilized to as-
sess activated or proliferating astroglia. Increased GFAP expression Pharmacological inactivation of the PFC prevents the
was apparent after all oligonucleotides within 100 m of the indwell- expression of drug-seeking behavior induced by a co-
ing cannula. Scale bar, 100 m. caine injection or an environmental stressor (Capriles et
al., 2003; McFarland and Kalivas, 2001). Also, the release
of glutamate from the PFC into the accumbens core
is required for cocaine-induced reinstatement of drugof D2 (AS-1  96.8  6.2, n  8, data normalized to
percent change from Sc) or mGluR2/3 (monomer, AS-1 seeking (McFarland et al., 2003). Based on the critical
role of the PFC in drug-seeking behavior, experiments100.1  1.3, n  8; dimer, AS-1  92.4  10.3, n  8)
(Figures 7A and 7B). were conducted to evaluate the hypothesis that the
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Figure 7. Elevation of AGS3 Parallels De-
creased Signaling through Gi-Coupled Re-
ceptors
(A) Three weeks of withdrawal from 1 week
of daily cocaine administration decreased
()-quinpirole stimulated Gi signaling at
D2/3 receptors in the PFC. This effect was
reversed by AS-1. Representative immunoblot
showing lack of effect of AS-1 on D2 levels
in PFC. (B) APDC stimulation of mGluR2/3
receptors and representative immunoblot of
mGluR2/3 monomer and dimer. The AS-1 	
Sal group was not examined. (C) Signaling
through Gs-coupled D1 dopamine recep-
tors was equivalent for all treatment groups. Data in each panel are shown as mean  SEM and were analyzed using a three-way ANOVA
with repeated measures over drug concentration. For mGluR2/3 and D2/3 receptors, there was a significant effect of nucleotide and drug
concentration but no interaction between oligonucleotide and concentration. No significant effect of factor or interaction between factors
was found for D1 receptors. Sc, scrambled; Coc, repeated cocaine; Sal, repeated saline. *p  0.01, comparing Sc 	 Coc with all other
treatment groups using posthoc three-way repeated-measures ANOVAs over drug concentration.
upregulation of AGS3 in the PFC during withdrawal from 28 in the group infused with scrambled oligonucleotide
(Figure 9C). In contrast, drug seeking was prevented bycocaine self administration mediates the reinstatement
of cocaine-primed drug seeking. infusion of either of the two antisense oligonucleotides
(Figure 9C). However, a second cocaine injection admin-Rats were trained to self administer cocaine by asso-
ciating a lever press with a cocaine infusion. Lever istered to the same animals 2 weeks after discontinuing
oligonucleotide infusion (day 42) elicited reliable rein-pressing for cocaine was extinguished by replacing co-
caine with saline, and during extinction training, AS-1, statement to a cocaine injection in all oligonucleotide
treatment groups (Figure 9D). The reduction in AGS3 byAS-2, or scrambled oligonucleotides were bilaterally in-
fused into the PFC for 2 weeks. No difference between AS-1 did not affect food-induced reinstatement in rats
trained to self administer food pellets instead of cocaine,oligonucleotide treatment groups was measured in the
number of days required to achieve the extinction crite- indicating that AS-1 did not produce motor or learning
deficits that prevented rats from responding to the co-rion (see Experimental Procedures). After 14 days of
oligonucleotide infusion, rats were administered a single caine-priming injection (Figure 9B).
injection of cocaine (10 mg/kg, i.p.) to reinstate drug
seeking (lever pressing for saline). Following this rein- Histology
The site of oligonucleotide infusion (Figure 6) or Tat-GPRstatement trial, oligonucleotide infusion was terminated
by removing the osmotic minipumps, and the propensity microinjection (Figure 3A) was primarily in the ventral
prelimbic and dorsal infralimbic cortex (Paxinos andto reinstate drug seeking was reassessed 2 weeks later
(Figure 9A). Watson, 1998). The dialysis probes were implanted into
the core of the nucleus accumbens with 15% of theDrug seeking was elicted by a cocaine injection on day
Figure 8. Reduction of AGS3 in the PFC by
Antisense Oligonucleotide Inhibits Locomo-
tor Sensitization
(A) Timeline summarizing the behavioral pro-
tocol. (B) The cumulative motor response to
the cocaine at days 1, 28, and 42. (C) The
motor response to cocaine injection on day
28 in the presence of oligonucleotide. (D) The
motor response to cocaine on day 42, 2
weeks after removing the osmotic minipumps
delivering oligonucleotide into the PFC. (E)
Two weeks of oligonucleotide infusion did not
affect the drug-naive animals to a novel envi-
ronment (open-field photocell chamber) or an
injection of saline (1 ml/kg, i.p.) or cocaine
(15 mg/kg, i.p.). The data are shown as cumu-
lative distance traveled over 60 min after in-
jection or exposure to a novel environment.
n  8 in all treatment groups. Data in (B)–(D)
were analyzed together using a three-way
ANOVA with repeated measures over time. A
significant effect was found over treatment
and time as well as a significant three-way interaction between treatment, oligonucleotide, and time. Data in (E) were analyzed using an
unpaired Student’s t test, and no differences were found. *p 0.05, using a least significant difference test for posthoc comparisons between
AS-1 and scrambled on day 28. 	p 0.05, comparing day 28 with day 42 in the AS-1 group. #p 0.05, comparing day 28 with day 1 in the
AS-1 group.
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Figure 9. Prefrontal Cortical AGS3 Regulates
Cocaine-Seeking Behavior
(A) Timeline outlining the experimental proto-
col. (B) Oligonucleotide infusion did not im-
pair food seeking. (C) Bilaterally reducing
AGS3 blocked the reinstatement of drug-
seeking behavior, while infusion with scram-
bled oligonucleotide had no effect. (D) Rein-
statement of drug seeking was initiated by a
cocaine injection 2 weeks after discontinuing
oligonucleotide infusion in all groups. Data
points depict mean active lever presses 
SEM, n  8 in all groups. Ext, total active
lever presses made during the extinction trial
the day prior to the cocaine-induced reinstate-
ment trial; Test, total active lever presses made
during cocaine reinstatement; Retest, total
active lever presses following a second ex-
tinction period and a second cocaine rein-
statement; Sc, scrambled oligonucleotide.
*p 0.05, using two-way ANOVA with repeated
measures over time using a least significant
difference test for posthoc comparisons.
active membrane dorsal or ventral to the accumbens Gi-G interaction and/or by altering the subcellular
localization of Gi-related signaling complexes (Blumercore, in the striatum or ventral limb of the accumbens
shell, respectively (e.g., see Figure 4 in McFarland et al. et al., 2002). It is presently unclear whether AGS3 ac-
tively promotes G protein subunit dissociation while[2003] for similar probe placements).
maintaining Gi in the GDP bound state, catches a tran-
siently nucleotide-free conformation of Gi that is thenDiscussion
stabilized by the binding of GDP, and/or binds GiGDP
during the G protein activation-deactivation cycle. Re-This study demonstrated that AGS3 expression was in-
duced in the PFC during withdrawal from repeated co- gardless of the precise molecular interactions, inhibition
of Gi by AGS3 in the PFC represents a unique mode ofcaine. When the increased PFC expression of AGS3
was mimicked by microinjecting Tat-GPR, drug-naive cocaine-induced plasticity. Reduced signaling through
Gi-coupled receptors has been previously describedanimals demonstrated a sensitization-like phenotype by
manifesting augmented motor activity and drug seeking within the addiction literature (Hummel and Unterwald,
2003; Nestler et al., 1990; Self et al., 1994; Shoji et al.,as well as increased extracellular glutamate in the core
compartment of the nucleus accumbens in response to 1997; Steketee and Kalivas, 1991; Xi et al., 2003, 2002;
Zhang et al., 2000), and the present data identify AGS3an acute injection of cocaine. When the elevation in
AGS3 was inhibited by infusing antisense oligonucleo- as a link between Gi signaling and cocaine-induced
behavioral and neurochemical plasticity. Preventing thetides into the PFC, the cocaine-induced reduction in Gi
coupling to mGluR2/3 and D2/3 receptors was reversed. expression of cocaine-induced behavioral sensitization
and the reinstatement of drug seeking by normalizingAntisense oligonucleotide infusion also reversed the be-
havioral consequences of repeated cocaine, including the expression of AGS3 and thereby restoring Gi sig-
naling is consistent with a role in addiction for elevatedreinstatement of drug seeking and locomotor sensiti-
zation. Taken together, these data indicate that upreg- AGS3 and the correspondingly reduced signaling though
Gi. However, it should be noted that elevated AGS3ulation of AGS3 in the PFC following withdrawal from
repeated cocaine administration contributes to cocaine- was not measured after 1 week of withdrawal, yet behav-
ioral sensitization and cocaine-primed reinstatement areinduced behavioral and neurochemical plasticity.
both present at that withdrawal time, indicating addi-
tional mechanisms.AGS3, Gi Regulation, and Addiction
AGS3 complexes GiGDP and thereby reduces signal- Exactly how compromised Gi coupling may contrib-
ute to other cellular adaptations associated with with-ing through Gi-coupled receptors in heterologous cells
and in brain tissue (Figure 7). AGS3 can scaffold up to drawal from repeated cocaine administration is not clear.
However, decreased Gi signaling may promote signal-four GDP bound Gi subunits via GPR repeats, which
interferes with signal transduction from G protein-cou- ing through other G proteins. The mutually antagonistic
effects of Giand Gs upon adenylyl cyclase are illustra-pled receptors to signaling pathways by disrupting the
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tive of this possibility, since Gs signaling through ade- decision making is impaired (Anderson et al., 1999). Ac-
nylyl cyclase, cAMP-dependent protein kinase (PKA), cordingly, dysfunction of this brain region is implicated
and proteins downstream from PKA such as -fosB in psychostimulant addiction and may underlie relapse
is elevated in the nucleus accumbens after repeated (Berke and Hyman, 2000; Goldstein and Volkow, 2002;
cocaine administration (Bibb et al., 2001; Nestler et al., Jentsch and Taylor, 1999; McFarland and Kalivas, 2001).
2001). Moreover, Gs-coupled D1 dopamine receptors The present study poses increased AGS3 in the PFC
have been shown to increase membrane excitability in as a potential pathological change contributing to drug
a PKA-dependent manner in pyramidal neurons of the seeking and behavioral sensitization. The precise mo-
PFC (Gonzalez-Islas and Hablitz, 2003), and D1 dopa- lecular mechanisms were not identified whereby the
mine receptor activation in the PFC is hypothesized to reduced Gi signaling resulting from enhanced AGS3
underlie the sustained network activity that allows for expression contributes to changes in prefrontal gluta-
focused behavior (Durstewitz and Seamans, 2002) such matergic output to the nucleus accumbens and the as-
as compulsive drug use (Berke and Hyman, 2000). Also, sociated cocaine-induced behavioral plasticity. How-
membrane potential in PFC pyramidal cells is bistable ever, it is clear that AGS3 levels in the PFC have a
(Steriade et al., 1993), and stimulation of D1 receptors profound influence on the expression of behaviors that
promotes and prolongs the more depolarized “up” state, are strongly associated with cocaine addiction. Inas-
from which the neuron can more easily emit action po- much as the PFC is playing a critical role in regulating
tentials in response to excitatory input (Lewis and the expression of motor sensitization and relapse to
O’Donnell, 2000). Consistent with pyramidal neurons be- drug seeking, the data in this study demonstrate that the
ing more easily stimulated, the membrane potential of level of AGS3 expression within the PFC is a molecular
pyramidal cells is no longer biphasic and rests closer determinant of this gatekeeper function.
to the up state after withdrawal from repeated cocaine
(Trantham et al., 2002). Also, the reinstatement of drug
Experimental Proceduresseeking is associated with increased glutamate release
into the accumbens core from prefrontal cortical gluta-
Subjects
matergic afferents (McFarland et al., 2003) and can be All experimental procedures were conducted in accordance with
blocked by dopamine antagonist administration into the the Guide for the Care and Use of Laboratory Animals, as adopted
PFC (Capriles et al., 2003; McFarland and Kalivas, 2001). by the NIH, and with the approval of an institutional animal care
These data suggest a hypothesis that high levels of and use committee. Male Sprague-Dawley rats (Harlan, Indianapolis,
IN; or Charles River, Wilmington, MA, for self-administration andAGS3 may alter dopaminergic signaling in the PFC such
microdialysis studies) were individually housed in an AAALAC-that D1-stimulated Gs signaling is preferentially acti-
approved facility. Animals were maintained on a 12 hr light-darkvated, which shifts pyramidal cells toward sustained
cycle (lights on at 7 a.m. or lights off at 7 a.m. for self-administration
activity, allowing for more focused behaviors. This studies) with ad libitum access to food and water unless otherwise
mechanism is consistent with the critical role of dopa- stated. Upon arrival, subjects were weighed and handled daily for
mine transmission at D1 receptors in the PFC in cocaine- 1 week. All experimentation was conducted during the light cycle
induced drug seeking and conditioned place preference (or dark cycle for self administration). Every effort was employed
to reduce animal discomfort during sacrifice through either rapid(Capriles et al., 2003; Sanchez et al., 2003), as well as
decapitation (for immunoblotting) or overdosing with pentobarbitala role for increased glutamate transmission in the pro-
(100 mg/kg, i.p.) for histological preparation of brain slices.jection from the PFC to the accumbens core in the rein-
statement of drug seeking (Capriles et al., 2003; McFar-
land and Kalivas, 2001; McFarland et al., 2003; Park et Surgery
al., 2002). Enhanced sequestering of Gi by the upregu- Osmotic Minipumps
Animals were anesthetized with pentobarbital (50 mg/kg, i.p.) andlation of AGS3 may also affect other signaling systems
bilateral 7 mm 28-gauge stainless steel microinjection cannulaeby increasing free G. For example, increased G
(Plastics 1, Roanoke, VA) lowered into the PFC (from Bregma: APcould impinge upon information processing within the
3.0, ML 2.0, DV 3.7 with manipulator arms set to a 20 angle)PFC by opening the G protein-coupled inwardly rectify-
(Paxinos and Watson, 1998). Cannulae were fitted with thick-wall
ing potassium (GIRK) channels (Lei et al., 2000), and PE 60 tubing attached to osmotic minipumps (Durect, Cupertino,
deletion of the gene encoding the Kir3.2 or Kir3.3 sub- CA). These pumps deliver 0.5 L per hour for 14 days, which equals
units of GIRK channels reduces intravenous cocaine self 504 pmol oligonucleotide per hemisphere within a 24 hr period when
filled with a 42 M solution. After 2 weeks, pumps were removedadministration (Morgan et al., 2003).
and tubes sealed after anesthetizing the animals briefly with Brevital
(45 mg/ kg, i.p.).Prefrontal Cortex and Addiction
Self Administration
No effective pharmacotherapy exists for the treatment Rats were anesthetized as described above and fitted with unilateral
of cocaine addiction, in part because the molecular ba- jugular catheters that were externalized on the animals’ backs to
sis of relapse to drug taking has yet to be elucidated attach to an infusion apparatus (McFarland and Kalivas, 2001).
Microinjection and Microdialysis Cannulae(National Institute on Drug Abuse, 2000). The most suc-
Animals were anesthetized as described above and 14 mm, 26-cessful treatment strategies rely on learning cognitive-
gauge stainless steel microinjection guide cannulae (Small Parts,behavioral coping skills that strengthen one’s ability to
Roanoke, VA) implanted into the PFC (Paxinos and Watson, 1998)self monitor and enable responding with greater self
at AP 3.0 mm, ML 2.0 mm, DV –2.7 mm from Bregma with manipula-
control when presented with a situation that would typi- tor arms set to a 20 angle from vertical. Dialysis guide cannulae
cally lead to relapse (Carroll, 1998). Appropriate func- (20-gauge, 14 mm, Small Parts, Roanoke, VA) were implanted over
tioning of the PFC is integral to self monitoring (Blake- the nucleus accumbens (AP 1.2 mm, ML 1.6 mm, DV 4.7 mm from
Bregma using a 6 angle from vertical) (Paxinos and Watson, 1998).more et al., 1998), and when this region is damaged,
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Behavioral Assays Food Self Administration and Reinstatement
To control for nonspecific behavioral effects, a separate group ofNoncontingent Cocaine Administration
and Behavioral Sensitization animals was trained to self administer food (McFarland and Kalivas,
2001) and implanted with osmotic minipumps during extinctionCocaine HCl was a gift from the National Institute on Drug Abuse.
Daily cocaine or saline injections (1.0 ml/kg, i.p.) were made for 1 training as described above. Rats were trained to lever press on an
FR-1 schedule of reinforcement (each reinforcement consisted ofweek (Pierce et al., 1996). On the first and last days of daily cocaine
administration, 15 mg/kg, i.p., was administered and locomotor ac- a single 45 mg Noyes food pellet) in daily 2 hr sessions. Once
stable responding was achieved, the schedule of reinforcement wastivity monitored in a photocell apparatus (Omnitech, Columbus, OH).
Locomotor activity was quantified as distance traveled (determined increased to FR-2 and then to FR-5. Subjects remained in mainte-
nance until lever press responding stabilized at less than 10% varia-by consecutive breaking of adjacent photobeams). Stereotypy was
estimated as consecutive breaking of the same photocell beam. tion across 3 consecutive days (ranging from 12 to 15 days of train-
ing). Subjects then entered behavioral extinction, in which leverAnimals were adapted to the photocell box for 60 min prior to injec-
tion of cocaine or saline. On the intervening days (days 2–6 of daily press responding no longer resulted in food delivery, and were
implanted with osmotic minipumps during extinction training asinjection), rats were administered 30 mg/kg, i.p., of cocaine. A single
investigator injected all rats at the same time each day during the described above. Rats were tested for their propensity to reinstate
responding for noncontingent food delivery 14 days after implantinglight cycle. If animals were used for immunoblotting, they were killed
at various times after discontinuing daily cocaine or saline adminis- the osmotic minipumps, and all subjects tested had met extinction
criteria (3 consecutive days of less than 10% maintenance rate oftration. If they were used for behavioral sensitization studies, the
tests for behavioral sensitization were conducted in the same photo- lever pressing). Rats received two pellets immediately upon initiation
and an additional 10 pellets for the first 20 min of the reinstatementcell box following administration of 15 mg/kg, i.p., cocaine.
To examine the effect of reducing AGS3 expression by antisense session (one pellet at 2 min intervals). Lever presses never resulted
in food delivery.oligonucleotide infusion into the PFC, after 1 week of withdrawal
from repeated cocaine, animals were fitted with indwelling microin-
jection cannulae attached to osmotic pumps as described above, Microdialysis
and either AS-1, AS-2, or the scrambled oligonucleotide was infused Concentric probes were constructed and dialysis conducted in the
bilaterally. Two weeks after beginning oligonucleotide infusion (day accumbens core (McFarland et al., 2003) following pretreatment of
28 of the experiment, see Figure 4A), the expression of behavioral the PFC with either Tat-GPR or Tat-mGPR and systemic cocaine
sensitization was assessed by injecting cocaine (15 mg/kg, i.p.). (15 mg/kg). Dialysis probes were inserted the night prior to the
The next day, animals were anesthetized briefly with Brevital (45 mg/ experiment. The next morning, microdialysis samples were obtained
kg, i.p.), the osmotic minipumps removed, and the tubing sealed. every 10 min (dialysis buffer flow rate  2.0 l/min). After collecting
Animals were again challenged with cocaine (15 mg/kg, i.p.) 2 weeks samples for 2 hr, rats were microinjected with Tat peptide as de-
after terminating oligonucleotide infusion to assess the expression scribed above and three more samples collected. Rats were then
of sensitization (day 42 of the experiment, see Figure 8A). injected with cocaine (15 mg/kg, i.p.) or saline and samples collected
In the Tat-GPR experiment, microinjection cannulae were im- for 2 more hours. The concentration of glutamate in the dialysis
planted over the PFC (see above), and 1 week later, the animals samples was measured using HPLC with fluorometric detection
were habituated to the photocell apparatus with a sham (vehicle (McFarland et al., 2003).
only) injection. On the day of the experiment, animals were habitu-
ated to the photocell chamber for 1 hr, obdurators removed, and
Immunoblotting1 l Tat-peptide infused over 90 s with 33-gauge stainless steel
After various withdrawal times (1, 7, 21, or 56 days after discontinu-microinjection needles for a total of 4.5 g Tat-peptide per hemi-
ing repeated cocaine or saline; 7 or 21 days after acute injection),sphere. After 2 additional minutes, needles were removed, obdura-
animals were decaptitated, and brain nuclei were excised and sub-tors replaced, and animals returned to the photocell chamber. Thirty
jected to blotting procedures (Bowers and Kalivas, 2003). Proteinsminutes later, animals were challenged with either cocaine (15 mg/
of interest were immunolabeled using specific antisera (AGS3 andkg, i.p.) or an identical volume of 0.9% saline (1 ml/kg, i.p.). Two
pan-GPR 1:3000 [Bernard et al., 2001]; G 1:3000, Gi1,3 1:1000,days of sham experiments followed, except that no microinjection
mGluR2/3 1:3000, Upstate, Lake Placid, NY), D2 receptor (1:1000,occurred. Five days later, an additional experiment was conducted,
Santa Cruz, CA), and activity of the secondary HRP conjugate (1:7000,and this process was repeated until all animals received all treat-
Upstate, Lake Placid, NY) determined using enhanced chemilumines-ments in a counterbalanced design (e.g., Tat-GPR 	 cocaine; Tat-
cence reagents and hyperfilm (Amersham Biosciences, Piscataway,GPR 	 saline; Tat-mGPR 	 cocaine; and Tat-mGPR 	 saline).
NJ). Immunolabeled bands were identified by their molecular weightCocaine Self Administration and Reinstatement
and quantified by densitometry (NIH Image 1.62).Animals were trained to self administer cocaine (0.25 mg/infusion)
(McFarland and Kalivas, 2001). Some rats served as yoked saline
controls and received an infusion of saline (0.9%) in the same tempo- Antisense Design and Delivery
ral pattern as that of cocaine self administered by a paired rat. After BLASTn searches (Altschul et al., 1994) (nonredundant, expect of
reaching criterion (10% deviation in the number of active lever 10,000 and word sizes of seven) were conducted to design potential
presses over the 2 hr daily trial), daily extinction trials were begun, DNA antisense and scrambled constructs that hybridize to AGS3
in which cocaine was replaced with saline. One week after beginning mRNA specifically or to no known gene, respectively. These con-
extinction, rats were given food ad libitum for 5 days prior to being structs were synthesized with 5
 phosphorothioate bonds (indicated
implanted in the PFC with microinjection cannulae attached to os- by an “*”) at each end and purified using reversed phase HPLC by
motic minipumps to continuously infuse oligonucleotide (see IDT (Coralville, IA). The scrambled sequence was 5
-T*A*C*C*G*GCT
above). Five days after beginning oligonucleotide infusion, extinc- ACGACCGGACCG*T*C*A*A*G-3
, AS-1 was 5
-C*C*A*G*A*CAG
tion training was reinstituted. All subjects had achieved extinction GAGGCCTCCATC*C*T*G*A*G-3
, and AS-2 was 5
-C*G*C*T*C*ACC
criterion by 14 days after reinstituting extinction training (10% of TTCCAGTGCCAG*C*T*C*C*A-3
. These constructs were placed into
the average number of active lever presses made during the last 3
osmotic minipumps at a concentration of 42 M in saline.
days of cocaine self administration), and the animals’ propensity
to reinstate drug-seeking behavior was assessed by administering
Tat-Peptide Constructioncocaine (5 or 10 mg/kg, i.p.) and monitoring active lever presses for
Tat-GPR GRKKRRQRRRPPTMGEEDFFDLLAKSQSKRMDDQRVD2 hr. During reinstatement testing, active lever presses resulted in
LAK, Tat-mGPR (Tat-GPRQ22A), which contains A in place of Q atsaline delivery. The following day, the osmotic minipumps were
residue 34 of the Tat-GR peptide, and Tat-fluorescein were synthe-removed as described above, and the rats received daily extinction
sized and purified by LSU Health Sciences Center Core Labs (Newtrials for 14 additional days, by which time all rats had achieved
Orleans, LA) and peptide mass and purity verified by matrix-assistedextinction criterion. After this second extinction period, all subjects
laser desorption ionization time of flight mass spectrometry. Pep-were given a cocaine injection (10 mg/kg, i.p.) and reinstatement
assessed as described above. tides were dissolved in 136 mM NaCl, 3 mM KCl, 10 mM Na2HPO4,
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2 mM NaH2PO4•H2O, and 1% glycerol for a final concentration of Low-affinity agonist binding was determined in the presence of 1
mM GppNHp (Roche, Indianapolis, IN). Binding reaction mixtures4.5 g/l.
were incubated at 25C for 30 min and terminated by rapid filtration
through glass fiber filters (Schleicher and Shuell, Keene, NH) with 4[35S]GTPS Binding for Rat Brain
4 ml washes of stop buffer (100 mM Tris [pH 7.4], 4C). RadioactivityOne week after the repeated cocaine treatment regimen, AS-1 and
bound to the filters was determined by liquid scintillation.the scrambled construct were delivered into opposite hemispheres
of the PFC for 2 weeks, animals were rapidly decapitated, and the
Histology and ImmunohistochemistryPFC was excised. Membrane preparation and binding were modified
Histological evaluation of cannula tract placement was conductedfrom Schaffhauser et al. (2000). Similarly treated hemispheres were
in all animals not used for immunobloting. Subjects were adminis-pooled from two rats whose locomotor response to repeated co-
tered an overdose of pentobarbital (100 mg/kg, i.p.) and the brainscaine was similar and homogenized on ice in 320 mM sucrose, 20
fixed via intracardiac infusion of formalin. Coronal sections (100 mmM HEPES, 10 mM EDTA, 0.002 M Brij 30 (Aldrich, Milwaukee,
thick) were obtained of the cannulae tracts and stained with cresylWI), and two tablets protease inhibitor cocktail (Roche, Mannheim)
violet. For immunocytochemistry, the brains were perfused with(pH 7.4) with a tissumizer (Teckmar, Cincinnati, OH) and spun down
phosphate-buffered saline followed by 4% paraformaldehyde. Alter-at 52,000 RCF for 20 min at 4C. The resulting pellet was resus-
nate sections through the cannulae tracts were processed for Nisslpended twice in 20 mM HEPES, 10 mM EDTA, 0.002 M Brij 30,
staining or GFAP immunoreactivity (Bowers and Kalivas, 2003). Tat-and two tablets protease inhibitor (pH 7.4) before being suspended
fluorescein transduction of cells in the PFC was evaluated within binding buffer (50 mM Tris, 2 mM MgCl2, 1 mM EGTA [pH 7.4]).
direct fluorescence, and chromatolysis was assessed with a NikonProtein concentrations were determined utilizing the Bio-Rad DC
Optiphot-II in brightfield.assay immediately prior to conducting the binding assay. Protein (30
g) from the membrane preparation, 1 U/ml adenosine deaminase
Statistical Analysis(Sigma, St. Louis, MO), 1 M GDP, and binding buffer (for a final
Statistical analysis of optical density measures obtained throughvolume of 1 ml) were incubated for 15 min at 37C with shaking
immunoblotting of AGS3 during withdrawal was determined by anprior to the addition of ligand (Tocris, Ellisville, MO) and 0.5 M
unpaired Student’s t test using StatView (Cary, NC). The effect of[35S]-GTPS (Amersham, Piscataway, NJ). Basal binding was deter-
antisense was determined using a paired Student’s t test, sincemined in the absence of agonist and nonspecific binding measured
opposite sides of the same brain were being compared. Analysis ofin the presence of 10 M unlabeled GTPS (Sigma, St. Louis, MO).
[35S]-GTPS binding studies was conducted with three-way ANOVAAfter 45 min, the reaction was terminated by filtration under vacuum
with repeated measures over dose followed by a two-way ANOVAthrough prewet GF/B glass fiber filters (Whatman, Maidstone, UK),
comparing treatment groups. A two-way ANOVA with repeated mea-followed by three washes with cold 50 mM Tris buffer (pH 7.4). Filters
sures over time, followed by least significant difference posthocwere extracted overnight with 10 ml of Cytoscint ES scintillation fluid
comparisons was utilized to analyze behavioral and neurochemical(ICN, Aurora, OH) and radioactivity measured by liquid scintillation
data (Milliken and Johnson, 1984). The absence of ordering effectsspectrophotometry (Beckman Coulter, Fullerton, CA). Each sample
in Figure 7A was determined using a three-way ANOVA.was run in triplicate and averaged. After background was sub-
tracted, each sample was normalized as percent change from base-
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